Non-Genetic Influences on Cystic Fibrosis Lung Disease: The Role of Sociodemographic Characteristics, Environmental Exposures, and Healthcare Interventions

Seminars in Respiratory and Critical Care Medicine

Volumn 24, Issue 6, 2003, Pages 639-652

  Schechter, Michael S ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Cystic fibrosis; Nutritional status; Outcome assessment (health care); Psychological stress; Quality of health care; Socioeconomic factors; Tobacco smoke pollution; Treatment refusal

Indexed keywords

TOBACCO SMOKE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ASTHMA; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; ETHNOLOGY; EVIDENCE BASED MEDICINE; GENE MUTATION; HEALTH CARE SYSTEM; HEALTH CENTER; HUMAN; LUNG DISEASE; MEASUREMENT; MORBIDITY; MORTALITY; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SOCIOECONOMICS; STRESS;

EID: 0347812925     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815660     Document Type: Review

References (166)

1. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9
2. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2001 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation; 2002
3. Dean M, Santis G. Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations. Hum Genet 1994;93:364-368
4. Kulczycki LL, Kostuch M, Bellanti JA. A clinical perspective of cystic fibrosis and new genetic findings: relationship of CFTR mutations to genotype-phenotype manifestations. Am J Med Genet 2003;116A:262-267
5. Lester LA, Kraut J, Lloyd-Still J, et al. Delta F508 genotype does not predict disease severity in an ethnically diverse cystic fibrosis population. Pediatrics 1994;93:114-118
6. Kerem E, Corey M, Kerem BS, et al. The relationship between genotype and phenotype in cystic fibrosis: analysis of the most common mutation (delta F508). N Engl J Med 1990;323:1517-1522
7. Hubert D, Bienvenu T, Desmazes-Dufeu N, et al. Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients. Eur Respir J 1996;9:2207-2214
8. Loubieres Y, Grenet D, Simon-Bouy B, et al. Association between genetically determined pancreatic status and lung disease in adult cystic fibrosis patients. Chest 2002;121:73-80
9. Rozmahel R, Wilschanski M, Matin A, et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet 1996;12:280-287
10. Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration 2000;67:117-133
11. Drumm ML. Modifier genes and variation in cystic fibrosis. Respir Res 2001;2:125-128
12. Acton JD, Wilmott RW. Phenotype of CF and the effects of possible modifier genes. Paediatr Respir Rev 2001;2:332-339
13. Mahadeva R, Lomas DA. Secondary genetic factors in cystic fibrosis lung disease. Thorax 2000;55:446
14. Salvatore F, Scudiero O, Castaldo G. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am J Med Genet 2002;111:88-95
15. Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996;143:1007-1017
16. Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995;48:1041-1049
17. Hudson I, Phelan PD. Are sex, age at diagnosis, or mode of presentation prognostic factors for cystic fibrosis? Pediatr Pulmonol 1987;3:288-297
18. O'Connor GT, Quinton HB, Kahn R, et al. Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pulmonol 2002;33:99-105
19. Rosenfeld M, Davis R, FitzSimmons R, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997;145:794-803
20. Guilbault C, Stotland P, Lachance C, et al. Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice. Immunology 2002;107:297-305
21. Allen JR, McCauley JC, Selby AM, et al. Differences in resting energy expenditure between male and female children with cystic fibrosis. J Pediatr 2003;142:15-19
22. Stallings VA. Gender, death and cystic fibrosis: is energy expenditure a component? J Pediatr 2003;142:4-6
23. Jolly DL, Nolan T, Moller J, Vimpani G. The impact of poverty and disadvantage on child health. J Paediatr Child Health 1991;27:203-217
24. Mackenbach JP, Kunst AE, Cavelaars AE, Groenhof F, Geurts JJ. Socioeconomic inequalities in morbidity and mortality in western Europe. The EU Working Group on Socioeconomic Inequalities in Health. Lancet 1997;349:1655-1659
25. Dimissie K, Ernst P, Hanley JA, Locher U, Menzies D, Becklake M. Socioeconomic status and lung function among primary school children in Canada. Am J Respir Crit Care Med 1996;153:719-723
26. Ernst P, Demissie K, Joseph L, Locher U, Becklake MR. Socioeconomic status and indicators of asthma in children. Am J Respir Crit Care Med 1995;152:570-575
27. Halfon N, Newacheck PW. Childhood asthma and poverty; differential impacts and utilization of health services. Pediatrics 1993;91:56-61
28. Finkelstein JA, Brown RW, Schneider LC, et al. Quality of care for preschool children with asthma: the role of social factors and practice setting. Pediatrics 1995;95:389-394
29. Weiss KB. Inner-city asthma: the epidemiology of an emerging US public health concern. Chest 1992;101:S362-S367
30. Britton J. Effects of social class, sex, and region of residence on age at death from cystic fibrosis. BMJ 1989;298:483-487
31. Macpherson C, Redmond AO, Leavy A, McMullan M. A review of cystic fibrosis children born to single mothers. Acta Paediatr 1998;87:397-400
32. Westwood AT. The prognosis of cystic fibrosis in the Western Cape region of South Africa. J Paediatr Child Health 1996;32:323-326
33. Schechter MS, Margolis PA. Relationship between socioeconomic status and disease severity in cystic fibrosis. J Pediatr 1998;132:260-264
34. Schechter MS, Shelton BJ, Margolis PA, FitzSimmons SC. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 2001;163:1331-1337
35. O'Connor GT, Quinton HB, Kneeland T, et al. Median household income and mortality rate in cystic fibrosis. Pediatrics 2003;111:e333-e339
36. Wilkinson RG. Income inequality, social cohesion, and health: clarifying the theory - a reply to Muntaner and Lynch. Int J Health Serv 1999;29:525-543
37. Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health 1997;18:341-378
38. Kennedy BP, Kawachi I, Glass R, Prothrow-Stith D. Income distribution, socioeconomic status, and self rated health in the United States: multilevel analysis. BMJ 1998;317:917-921
39. Kawachi I, Kennedy BP. Income inequality and health: pathways and mechanisms. Health Serv Res 1999;34:215-227
40. Reijneveld SA. The impact of individual and area characteristics on urban socioeconomic differences in health and smoking. Int J Epidemiol 1998;27:33-40
41. Smith GD, Hart C, Blane D, Hole D. Adverse socioeconomic conditions in childhood and cause specific adult mortality: prospective observational study. BMJ 1998;316:1631-1635
42. Gazmararian JA, Adams MM, Pamuk ER. Associations between measures of socioeconomic status and maternal health behavior. Am J Prev Med 1996;12:108-115
43. Davey Smith G, Hart C, Hole D, et al. Education and occupational social class: which is the more important indicator of mortality risk? J Epidemiol Community Health 1998;52:153-160
44. Liberatos P, Link BG, Kelsey JL. The measurement of social class in epidemiology. Epidemiol Rev 1988;10:87-120
45. Johnson NJ, Sorlie PD, Backlund E. The impact of specific occupation on mortality in the U.S. National Longitudinal Mortality Study. Demography 1999;36:355-367
46. Fein O. The influence of social class on health status: American and British research on health inequalities. J Gen Intern Med 1995;10:577-586
47. Zill N. Parental schooling and children's health. Public Health Rep 1996;111:34-43
48. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott-Raven; 1998
49. Holahan J, Rowland D, Feder J, Heslam D. Explaining the recent growth in Medicaid spending. Health Aff 1993;12:177-193
50. Pincus T, Esther R, DeWalt DA, Callahan LF. Social conditions and self-management are more powerful determinants of health than access to care. Ann Intern Med 1998;129:406-411
51. Schmitzberger R, Rhomberg K, Buchele H, et al. Effects of air pollution on the respiratory tract of children. Pediatr Pulmonol 1993;15:68-74
52. Apter AJ, Reisine ST, Affleck G, Barrows E, ZuWallack RL. Adherence with twice-daily dosing of inhaled steroids: socioeconomic and health-belief differences. Am J Respir Crit Care Med 1998;157:1810-1817
53. Schenker MB, Samet JM, Speizer FE. Risk factors for childhood respiratory disease: the effect of host factors and home environmental exposures. Am Rev Respir Dis 1983;128:1038-1043
54. Stoddard JJ, Miller T. Impact of parental smoking on the prevalence of wheezing respiratory illness in children. Am J Epidemiol 1995;141:96-102
55. Tager IB, Ngo L, Hanrahan JP. Maternal smoking during pregnancy. Am J Respir Crit Care Med 1995;152:977-983
56. Rubin BK. Exposure of children with cystic fibrosis to environmental tobacco smoke. N Engl J Med 1990;323:782-788
57. Smyth A, O'Hea U, Williams G, Smyth R, Heaf D. Passive smoking and impaired lung function in cystic fibrosis. Arch Dis Child 1994;71:353-354
58. Kovesi T, Corey M, Levison H. Passive smoking and lung function in cystic fibrosis. Am Rev Respir Dis 1993;148:1266-1271
59. Campbell PW III, Parker RA, Roberts BT, Krishnamani MR, Phillips JA III. Association of poor clinical status and heavy exposure to tobacco smoke in patients with cystic fibrosis who are homozygous for the F508 deletion. J Pediatr 1992;120:261-264
60. Gilljam H, Stenlund C, Ericsson-Hollsing A, Strandvik B. Passive smoking in cystic fibrosis. Respir Med 1990;84:289-291
61. Schuster MA, Franke T, Pham CB. Smoking patterns of household members and visitors in homes with children in the United States. Arch Pediatr Adolesc Med 2002;156:1094-1100
62. Butz AM, Rosenstein BJ. Passive smoking among children with chronic respiratory disease. J Asthma 1992;29:265-272
63. Nelson DE, Emont SL, Brackbill RM, Cameron LL, Peddicord J, Fiore MC. Cigarette smoking prevalence by occupation in the United States: a comparison between 1978 to 1980 and 1987 to 1990. J Occup Med 1994;36:516-525
64. Haire-Joshu D, Morgan G, Fisher EB Jr. Determinants of cigarette smoking. Clin Chest Med 1991;4:711-725
65. Schechter MS. Poverty and Disease Severity in CF: Social and Biological Implications. Pediatr Pulmonol Suppl 1999;119:156-157
66. Burns JL, Gibson RL, McNamara S, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001;183:444-452
67. Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr 1990;116:714-719
68. Nixon GM, Armstrong DS, Carzino R, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001;138:699-704
69. Hudson VL, Wielinski CL, Regelmann WE. Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years. J Pediatr 1993;122:854-860
70. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002;34:91-100
71. Pamukcu A, Bush A, Buchdahl R. Effects of Pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr Pulmonol 1995;19:10-15
72. Jones AM, Dodd ME, Doherty CJ, Govan JR, Webb AK. Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa. Thorax 2002;57:924-925
73. Henry RL, Mellis CM, Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 1992;12:158-161
74. Johnson C, Butler SM, Konstan MW, Morgan W, Wohl ME. Factors influencing outcomes in cystic fibrosis: a center-based analysis. Chest 2003;123:20-27
75. Maselli JH, Sontag MK, Norris JM, MacKenzie T, Wagener JS, Accurso FJ. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening. Pediatr Pulmonol 2003;35:257-262
76. Ratjen F, Comes G, Paul K, Posselt HG, Wagner TO, Harms K. Effect of continuous antistaphylococcal therapy on the rate of P. aeruginosa acquisition in patients with cystic fibrosis. Pediatr Pulmonol 2001;31:13-16
77. Tummler B, Koopmann U, Grothues D, Weissbrodt H, Steinkamp G, von der Hardt H. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients. J Clin Microbiol 1991;29:1265-1267
78. Kosorok MR, Jalaluddin M, Farrell PM, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol 1998;26:81-88
79. Farrell PM, Shen G, Splaingard M, et al. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics 1997;100:E2
80. Hoiby N, Pedersen SS. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr Scand 1989;78:395-404
81. Pedersen SS, Jensen T, Pressler T, Hoiby N, Rosendal K. Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection? Acta Paediatr Scand 1986;75:840-845
82. Kerem E, Corey M, Stein R, Gold R, Levison H. Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients. Pediatr Infect Dis J 1990;9:494-498
83. Armstrong D, Grimwood K, Carlin JB, et al. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr Pulmonol 1998;26:371-379
84. LiPuma JJ. Burkholderia cepacia: management issues and new insights. Clin Chest Med 1998;19:473-486
85. Ledson MJ, Gallagher MJ, Jackson M, Hart CA, Walshaw MJ. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 2002;57:142-145
86. McCloskey M, McCaughan J, Redmond AO, Elborn JS. Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis. Ir J Med Sci 2001;170:28-31
87. Muhdi K, Edenborough FP, Gumery L, et al. Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic. Thorax 1996;51:374-377
88. Lewin LO, Byard PJ, Davis PB. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol 1990;43:125-131
89. Chen JS, Witzmann KA, Spilker T, Fink RJ, LiPuma JJ. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr 2001;139:643-649
90. Govan JR, Brown PH, Maddison J, et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993;342:15-19
91. Whiteford ML, Wilkinson JD, McColl JH, et al. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax 1995;50:1194-1198
92. Wang EE, Prober CG, Manson B, Corey M, Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med 1984;311:1653-1658
93. Smyth AR, Smyth RL, Tong CY, Hart CA, Heaf DP. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child 1995;73:117-120
94. Hiatt PW, Grace SC, Kozinetz CA, et al. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics 1999;103:619-626
95. Collinson J, Nicholson KG, Cancio E, et al. Effects of upper respiratory tract infections in patients with cystic fibrosis. Thorax 1996;51:1115-1122
96. Gardner G, Frank AL, Taber LH. Effects of social and family factors on viral respiratory infection and illness in the first year of life. J Epidemiol Community Health 1984;38:42-48
97. Bor DH, Epstein PR. Pathogenesis of respiratory infection in the disadvantaged. Semin Respir Infect 1991;6:194-203
98. Busse WW, Kiecolt-Glaser JK, Coe C, Martin RJ, Weiss ST, Parker SR. NHLBI Workshop summary: stress and asthma. Am J Respir Crit Care Med 1995;151:249-252
99. Patterson JM, Budd J, Goetz D, Warwick WJ. Family correlates of a 10-year pulmonary health trend in cystic fibrosis. Pediatrics 1993;91:383-389
100. Wallander JL, Varni JW. Adjustment in children with chronic physical disorders: programmatic research on a disability-stress-coping model. In: LaGreca AM, Siegal L, Wallander JL, Walker CE, eds. Stress and Coping in Child Health. New York: Guilford Press; 1992:279-298
101. Quittner AL, DiGirolamo AM, Michel M, Eigen H. Parental response to cystic fibrosis: a contextual analysis of the diagnosis phase. J Pediatr Psychol 1992;17:683-704
102. Wright RJ, Steinbach SF. Violence: an unrecognized environmental exposure that may contribute to greater asthma morbidity in high risk inner-city populations. Environ Health Perspect 2001;109:1085-1089
103. Wright RJ, Rodriguez M, Cohen S. Review of psychosocial stress and asthma: an integrated biopsychosocial approach. Thorax 1998;53:1066-1074
104. Quittner AL, DiGirolamo AM. Family adaptation to childhood disability and illness. In: Ammerman RT, Campo JV, eds. Handbook of Pediatric Psychology and Psychiatry. Boston: Allyn & Bacon; 1998:70-102
105. Patterson JM, McCubbin HI, Warwick WJ. The impact of family functioning on health changes in children with cystic fibrosis. Soc Sci Med 1990;31:159-164
106. Thompson RJ, Gustafson KE, Hamlett KW, Spock A. Psychological adjustment of children with cystic fibrosis: the role of child cognitive processes and maternal adjustment. J Pediatr Psychol 1992;17:741-755
107. Borowitz D. The interrelationship of nutrition and pulmonary function in patients with cystic fibrosis. Curr Opin Pulm Med 1996;2:457-461
108. Schoni MH, Casaulta-Aebischer C. Nutrition and lung function in cystic fibrosis patients: review. Clin Nutr 2000;19:79-95
109. Steinkamp G, von der Hardt H. Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis. J Pediatr 1994;124:244-249
110. Steinkamp G, Wiedemann B. Relationship between nutritional status and lung function in cystic fibrosis: cross-sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax 2002;57:596-601
111. Konstan MW, Butler SM, Johnson CA, Wagener JS, Lai HC, Morgan WJ. The relationship between nutritional status in early life and pulmonary function in cystic fibrosis. Pediatr Pulmonol Suppl 1999;19:155-1156
112. Walker SA, Gozal D. Pulmonary function correlates in the prediction of long-term weight gain in cystic fibrosis patients with gastrostomy tube feedings. J Pediatr Gastroenterol Nutr 1998;27:53-56
113. James WP, Nelson M, Ralph A, Leather S. Socioeconomic determinants of health: the contribution of nutrition to inequalities in health. BMJ 1997;314:1545-1549
114. Kawchak DA, Zhao H, Scanlin TF, Tomezsko JL, Cnaan A, Stallings VA. Longitudinal, prospective analysis of dietary intake in children with cystic fibrosis. J Pediatr 1996;129:119-129
115. Marcus MS, Sondel SA, Farrell PM, et al. Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention. Am J Clin Nutr 1991;54:578-585
116. Anthony H, Paxton S, Bines J, Phelan P. Psychosocial predictors of adherence to nutritional recommendations and growth outcomes in children with cystic fibrosis. J Psychosom Res 1999;47:623-634
117. Willis E, Miller R, Wyn J. Gendered embodiment and survival for young people with cystic fibrosis. Soc Sci Med 2001;53:1163-1174
118. Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992;327:1785-1788
119. Orenstein DM, Nixon PA. Exercise performance and breathing patterns in cystic fibrosis: male-female differences and influence of resting pulmonary function. Pediatr Pulmonol 1991;10:101-105
120. Walters S. Sex differences in weight perception and nutritional behaviour in adults with cystic fibrosis. J Hum Nutr Diet 2001;14:83-91
121. Abbott J, Conway S, Etherington C, et al. Perceived body image and eating behavior in young adults with cystic fibrosis and their healthy peers. J Behav Med 2000;23:501-517
122. Truby H, Paxton AS. Body image and dieting behavior in cystic fibrosis. Pediatrics 2001;107:E92
123. Lai HC, Kosorok MR, Laxova A, Makholm LM, Farrell PM. Delayed diagnosis of US females with cystic fibrosis. Am J Epidemiol 2002;156:165-173
124. Braun L. Race, ethnicity, and health: can genetics explain disparities? Perspect Biol Med 2002;45:159-174
125. Hamosh A, FitzSimmons SC, Macek M Jr, Knowles MR, Rosenstein BJ, Cutting GR. Comparison of the clinical manifestation of cystic fibrosis in black and white patients. J Pediatr 1998;132:255-259
126. Aligne CA, Auinger P, Byrd RS, Weitzman M. Risk factors for pediatric asthma: contributions of poverty, race, and urban residence. Am J Respir Crit Care Med 2000;162:873-877
127. Litonjua AA, Carey VJ, Weiss ST, Gold DR. Race, socioeconomic factors, and area of residence are associated with asthma prevalence. Pediatr Pulmonol 1999;28:394-401
128. Miller JE. The effects of race/ethnicity and income on early childhood asthma prevalence and health care use. Am J Public Health 2000;90:428-430
129. Persky VW, Slezak J, Contreras A, et al. Relationships of race and socioeconomic status with prevalence, severity, and symptoms of asthma in Chicago school children. Ann Allergy Asthma Immunol 1998;81:266-271
130. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41:583-591
131. Thomas J, Cook DJ, Brooks D. Chest physical therapy management of patients with cystic fibrosis: a meta-analysis. Am J Respir Crit Care Med 1995;151:846-850
132. Fuchs HJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med 1994;331:637-642
133. McCoy K, Hamilton S, Johnson C. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group. Chest 1996;110:889-895
134. Quan JM, Tiddens HA, Sy JP, et al. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. J Pediatr 2001;139:813-820
135. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 1999;340:23-30
136. Equi A, Balfour-Lynn IM, Bush A, Rosenthal M. Long-term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet 2002;360:978-984
137. Frederiksen B, Lanng S, Koch C, Hoiby N. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol 1996;21:153-158
138. Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997;23:330-335
139. Rosenecker J, Hofler R, Steinkamp G, et al. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res 2001;6:345-350
140. Aris RM, Lester GE, Renner JB, et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med 2000;162:941-946
141. Colombo C, Battezzati PM, Crosignani A, et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology 2002;36:1374-1382
142. Subcommittee TCFFCCaG. Cystic Fibrosis Foundation guidelines for patient services, evaluation, and monitoring in cystic fibrosis centers. Am J Dis Child 1990;144:1311-1312
143. Collins CE, MacDonald-Wicks L, Rowe S, O'Loughlin EV, Henry RL. Normal growth in cystic fibrosis associated with a specialised centre. Arch Dis Child 1999;81:241-246
144. Mahadeva R, Webb K, Westerbeek RC, et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross-sectional study. BMJ 1998;316:1771-1775
145. Adler NE, Boyce WT, Chesney MA, Folkman S, Syme SI. Socioeconomic inequalities in health. JAMA 1993;269:3140-3145
146. Curtis JR, Burke W, Kassner A, Aitkin ML. Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis. Am J Respir Crit Care Med 1997;155:1921-1924
147. Hahn B, Flood AB. No insurance, public insurance, and private insurance: do these options contribute to differences in general health? J Health Care Poor Underserved 1995;6:41-59
148. Henley LD, Hill ID. Errors, gaps, and misconceptions in the disease-related knowledge of cystic fibrosis patients and their families. Pediatrics 1990;85:1008-1014
149. Henley LD, Hill ID. Global and specific disease-related information needs of cystic fibrosis patients and their families. Pediatrics 1990;85:1015-1021
150. Konstan MW, Butler SM, Schidlow DV, Morgan WJ, Julius JR, Johnson CA. Patterns of medical practice in cystic fibrosis, II: Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Pediatr Pulmonol 1999;28:248-254
151. Konstan MW, Butler SM, Schidlow DV, Morgan WJ, Julius JR, Johnson CA. Patterns of medical practice in cystic fibrosis, I: Evaluation and monitoring of health status of patients. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Pediatr Pulmonol 1999;28:242-247
152. Abbott J, Dodd M, Webb AK. Health perceptions and treatment adherence in adults with cystic fibrosis. Thorax 1996;51:1233-1238
153. Conway SP, Pond MN, Hamnett T, Watson A. Compliance with treatment in adult patients with cystic fibrosis. Thorax 1996;51:29-33
154. Quittrier AL, Espelage DL, Ievers-Landis C, Drotar D. Measuring adherence to medical treatments in childhood chronic illness: considering multiple methods and sources of information. J Clin Psychol Med Settings 2000;7:41-54
155. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984;6:592-599
156. Lask B. Nonadherence to treatment in cystic fibrosis. J R Soc Med 1994;87:25-27
157. Koocher GP, McGrath ML, Gudas LJ. Typologies of non-adherence in cystic fibrosis. J Dev Behav Pediatr 1990;11:353-358
158. Gudas LJ, Koocher GP, Wypij D. Perceptions of medical compliance in children and adolescents with cystic fibrosis. J Dev Behav Pediatr 1991;12:236-242
159. DiMatteo MR. Enhancing patient adherence to medical recommendations. JAMA 1994;271:79-82
160. Eddy ME, Carter BD, Kronenberger WG, et al. Parent relationships and compliance in cystic fibrosis. J Pediatr Health Care 1998;12:196-202
161. Ievers CE, Brown RT, Drotar D, Caplan D, Pishevar BS, Lambert RG. Knowledge of physician prescriptions and adherence to treatment among children with cystic fibrosis and their mothers. J Dev Behav Pediatr 1999;20:335-343
162. Quittner AL, Drotar D, Ievers-Landis C, Seidner D, Slocum N, Jacobsen J. Adherence to medical teatments in adolescents with cystic fibrosis: The development and evaluation of family-based interventions. In: Drotar D, ed. Promoting Adherence to Medical Treatment in Childhood Chronic Illness: Concepts, Methods, and Interventions. Mahwah, NJ: Erlbaum Associates; 2000:383-407
163. Clinical Practice Guidelines for Cystic Fibrosis Committee. Clinical Practice Guidelines for Cystic Fibrosis. Bethesda: Cystic Fibrosis Foundation; 1997
164. Schechter MS. Demographic and Center-Related Characteristics Associated with Low Weight in Pediatric CF Patients. Pediatric Pulmonology 2002;suppl 22:156-157
165. Berwick DM. Continuous improvement as an ideal in health care. N Engl J Med 1989;320:53-56
166. Institute of Medicine Committee on Quality Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press; 2001